Phenylephrine effects on cardiac contractility adenyl cyclase, and phosphorylase.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000096:biosynthesis; D004336:Drug Antagonism; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D005964:Glucosyltransferases / Q000378:metabolism*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006325:Heart Atria; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology*; D010477:Perfusion; D010656:Phenylephrine / Q000008:administration & dosage / Q000494:pharmacology*; D006005:Phosphorylases / Q000378:metabolism; D011817:Rabbits; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology
D010656:Phenylephrine; D013806:Theophylline; D014043:Tolazoline; D000242:Cyclic AMP; D005964:Glucosyltransferases; D006005:Phosphorylases; D000262:Adenylyl Cyclases; D005459:Fluorides; D004837:Epinephrine